Risk factors for Creutzfeldt-Jakob disease: A reanalysis of case-control studies

被引:104
作者
Wientjens, DPWM
Davanipour, Z
Hofman, A
Kondo, K
Matthews, WB
Will, RG
vanDuijn, CM
机构
[1] ERASMUS UNIV ROTTERDAM,SCH MED,DEPT EPIDEMIOL & BIOSTAT,3000 DR ROTTERDAM,NETHERLANDS
[2] ERASMUS UNIV ROTTERDAM,SCH MED,DEPT NEUROL,3000 DR ROTTERDAM,NETHERLANDS
[3] UNIV SO CALIF,LOS ANGELES,CA
[4] HOKKAIDO UNIV,DEPT PUBL HLTH,SAPPORO,HOKKAIDO 060,JAPAN
[5] UNIV OXFORD,RADCLIFFE INFIRM,DEPT CLIN NEUROL,OXFORD OX2 6HE,ENGLAND
[6] WESTERN GEN HOSP,DEPT CLIN NEUROSCI,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND
关键词
D O I
10.1212/WNL.46.5.1287
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
To review the evidence for risk factors of Creutzfeldt-Jakob disease (CJD), we pooled and reanalyzed the raw data of three case-control studies. The pooled data set comprised 178 patients and 333 control subjects. The strength of association between CJD and putative risk factors was assessed by computing the odds ratio as estimate of the relative risk. The risk of CJD was statistically significantly increased for subjects with a family history of CJD (odds ratio = 19.1; 95% CI 1.1 to 348.0). Further, there was a significant association between the risk of CJD and a history of psychotic disease (odds ratio = 9.9; 95% CI 1.1 to 86.1). Although not significantly increased, there was an elevated risk of CJD for subjects with a family history of dementia, a history of poliomyelitis, subjects employed as health professionals, and subjects ever exposed to cows and sheep. No association could be shown with organ meat consumption, including brain. The negative results of this reanalysis reassures the absence of a common risk factor in all CJD patients. However, the ongoing epidemiologic surveillance of CJD in several European countries may provide more evidence to exclude any environmental exposure early in childhood.
引用
收藏
页码:1287 / 1291
页数:5
相关论文
共 26 条
[1]   INCIDENCE OF CREUTZFELDT-JAKOB-DISEASE IN EUROPE IN 1993 [J].
ALPEROVITCH, A ;
BROWN, P ;
WEBER, T ;
POCCHIARI, M ;
HOFMAN, A ;
WILL, R .
LANCET, 1994, 343 (8902) :918-918
[2]   THE APOLIPOPROTEIN-E ALLELES AS MAJOR SUSCEPTIBILITY FACTORS FOR CREUTZFELDT-JAKOB-DISEASE [J].
AMOUYEL, P ;
VIDAL, O ;
LAUNAY, JM ;
LAPLANCHE, JL .
LANCET, 1994, 344 (8933) :1315-1318
[3]  
BERNOULLI C, 1977, LANCET, V1, P478
[4]   CREUTZFELDT-JAKOB DISEASE - CASE-CONTROL STUDY [J].
BOBOWICK, AR ;
BRODY, JA ;
MATTHEWS, MR ;
ROOS, R ;
GAJDUSEK, DC .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1973, 98 (05) :381-394
[5]   POTENTIAL EPIDEMIC OF CREUTZFELDT-JAKOB DISEASE FROM HUMAN GROWTH-HORMONE THERAPY [J].
BROWN, P ;
GAJDUSEK, DC ;
GIBBS, CJ ;
ASHER, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (12) :728-731
[6]   THE EPIDEMIOLOGY OF CREUTZFELDT-JAKOB DISEASE - CONCLUSION OF A 15-YEAR INVESTIGATION IN FRANCE AND REVIEW OF THE WORLD LITERATURE [J].
BROWN, P ;
CATHALA, F ;
RAUBERTAS, RF ;
GAJDUSEK, DC ;
CASTAIGNE, P .
NEUROLOGY, 1987, 37 (06) :895-904
[7]   CREUTZFELDT-JAKOB DISEASE IN A RECIPIENT OF HUMAN PITUITARY-DERIVED GONADOTROPIN [J].
COCHIUS, JI ;
BURNS, RJ ;
BLUMBERGS, PC ;
MACK, K ;
ALDERMAN, CP .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1990, 20 (04) :592-593
[8]   INHERITED PRION DISEASE WITH 144 BASE PAIR GENE INSERTION .2. CLINICAL AND PATHOLOGICAL FEATURES [J].
COLLINGE, J ;
BROWN, J ;
HARDY, J ;
MULLAN, M ;
ROSSOR, MN ;
BAKER, H ;
CROW, TJ ;
LOFTHOUSE, R ;
POULTER, M ;
RIDLEY, R ;
OWEN, F ;
BENNETT, C ;
DUNN, G ;
HARDING, AE ;
QUINN, N ;
DOSHI, B ;
ROBERTS, GW ;
HONAVAR, M ;
JANOTA, I ;
LANTOS, PL .
BRAIN, 1992, 115 :687-710
[9]   GENETIC PREDISPOSITION TO IATROGENIC CREUTZFELDT-JAKOB DISEASE [J].
COLLINGE, J ;
PALMER, MS ;
DRYDEN, AJ .
LANCET, 1991, 337 (8755) :1441-1442
[10]   PRION DEMENTIA WITHOUT CHARACTERISTIC PATHOLOGY [J].
COLLINGE, J ;
OWEN, F ;
POULTER, M ;
LEACH, M ;
CROW, TJ ;
ROSSOR, MN ;
HARDY, J ;
MULLAN, MJ ;
JANOTA, I ;
LANTOS, PL .
LANCET, 1990, 336 (8706) :7-9